Carbapenems (Q28286055)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Carbapenems	scientific article

Statements

scholarly article

0 references

Carbapenems (English)

0 references

carbapenem antibiotic

0 references

Bernard Allaouchiche

3

object named as

Bernard Allaouchiche

0 references

author name string

Dominique Breilh

1

0 references

Jeannette Texier-Maugein

2

0 references

Marie-Claude Saux

4

0 references

Emmanuel Boselli

5

0 references

language of work or name

0 references

publication date

February 2013

0 references

Journal of Chemotherapy

0 references

25

0 references

1-17

0 references

1

0 references

Carbapenems: past, present, and future

1 reference

https://api.crossref.org/works/10.1179/1973947812Y.0000000032

20 April 2017

Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use

1 reference

https://api.crossref.org/works/10.1179/1973947812Y.0000000032

20 April 2017

Carbapenemases: the versatile beta-lactamases

1 reference

https://api.crossref.org/works/10.1179/1973947812Y.0000000032

20 April 2017

Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections

1 reference

https://api.crossref.org/works/10.1179/1973947812Y.0000000032

20 April 2017

Overview of seizure-inducing potential of doripenem

1 reference

https://api.crossref.org/works/10.1179/1973947812Y.0000000032

20 April 2017

Carbapenems: a potent class of antibiotics

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

New developments in carbapenems

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Doripenem: position in clinical practice

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Parenteral carbapenems

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

In vitro activity of doripenem against Acinetobacter baumannii clinical isolates

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Characteristics of doripenem: a new broad-spectrum antibiotic

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Relevance of resistance levels to carbapenems and integron-borne blaIMP-1, blaIMP-7, blaIMP-10 and blaVIM-2 in clinical isolates of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (bla KPC) variants

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Comparative antianaerobic activities of doripenem determined by MIC and time-kill analysis

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Antimicrobial-induced release of endotoxin from Pseudomonas aeruginosa: comparison of in vitro and animal models

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Comparative pharmacokinetics of the carbapenems: clinical implications

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Doripenem: a review of its use in the treatment of bacterial infections.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Pharmacokinetics of ertapenem in healthy young volunteers.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Carbapenems in the USA: focus on doripenem

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Multiple-dose pharmacokinetics of imipenem-cilastatin

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Comparative disposition of [14C]ertapenem, a novel carbapenem antibiotic, in rat, monkey and man.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Disposition, metabolism, and excretion of [14C]doripenem after a single 500-milligram intravenous infusion in healthy men.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Comparative review of the carbapenems

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

An overview of the pharmacology of imipenem/cilastatin

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Pneumonia: the impact of risk factors on the outcome of treatment with meropenem and ceftazidime.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: A multicenter, prospective, randomized, open-label study

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Clinical evaluation of meropenem versus ceftazidime for the treatment of Pseudomonas spp. infections in cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Meta-analysis of the clinical outcome of carbapenem monotherapy in the adjunctive treatment of intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery. Meropenem Study Group.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Antibiotic monotherapy with meropenem in the surgical management of intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intra-abdominal infections.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Meta-analysis: ertapenem for complicated intra-abdominal infections.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Newer carbapenems for urinary tract infections

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Pharmacokinetic issues for antibiotics in the critically ill patient

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Is continuous infusion of beta-lactam antibiotics worthwhile?--efficacy and pharmacokinetic considerations

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Optimal meropenem concentrations to treat multidrug-resistant Pseudomonas aeruginosa septic shock

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Continuous infusion of beta-lactams.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Relationship of minimal inhibitory concentration and bactericidal activity to efficacy of antibiotics for treatment of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Doripenem monohydrate, a broad-spectrum carbapenem antibiotic

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

In vitro antimicrobial activity of doripenem, a new carbapenem

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Comparative in-vitro activities of ertapenem against aerobic bacterial pathogens isolated from patients with complicated intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme: report of year five (2003).

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Activity of a novel carbapenem, doripenem, against anaerobic pathogens

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

The utility of diffusion chambers as models for the description of drug disposition.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Meropenem pharmacokinetics and penetration into an inflammatory exudate

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Tissue penetration of Meropenem in patients undergoing gynecologic surgery

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

The pharmacokinetics and pharmacodynamics of meropenem in the cerebrospinal fluid of neurosurgical patients

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Tissue penetration by ertapenem, a parenteral carbapenem administered once daily, in suction-induced skin blister fluid in healthy young volunteers

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Ertapenem peritoneal fluid concentrations in adult surgical patients

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Intraabdominal tissue concentration of ertapenem

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Penetration of ertapenem into different pulmonary compartments of patients undergoing lung surgery

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Diffusion of ertapenem into bone and synovial tissues.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Peritoneal penetration of doripenem after intravenous administration in abdominal-surgery patients

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Penetration of doripenem into prostatic tissue following intravenous administration in prostatectomy patients

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Meropenem and continuous renal replacement

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Doripenem pharmacokinetics in critically ill patients receiving continuous hemodiafiltration (CHDF).

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Ertapenem versus ceftriaxone and metronidazole as treatment for complicated intra-abdominal infections.

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000032

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28286055&oldid=1951490352"